Cigarette smoke stimulates VEGF-C expression in cervical intraepithelial neoplasia (CIN) 1 and 2 lesions

International Journal of Clinical Oncology

Volumn 17, Issue 5, 2012, Pages 498-504

  Inamine, Morihiko ^a   Nagai, Yutaka ^a   Mitsuhashi, Akira ^b   Nagase, Satoru ^c   Yaegashi, Nobuo ^c   Yoshikawa, Hiroyuki ^d   Aoki, Yoichi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cigarette smoke; CIN 1 2; HPV; VEGF C

Indexed keywords

CIGARETTE SMOKE; KI 67 ANTIBODY; KI 67 ANTIGEN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY; VASCULOTROPIN C; VASCULOTROPIN C ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER REGRESSION; CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 1; CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE 2; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS TYPING; WART VIRUS;

ADULT; CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84869492734     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0322-3     Document Type: Article

References (22)

1. Matsuda T, Marugame T, Kamo KI et al (2011) Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 41:139-147
2. IARC (2004) Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans, vol 83. IARC, Lyon
3. Kapeu AS, Luostarinen T, Jellum E et al (2009) Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol 169:480-488
4. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V et al (2006) Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 118:1481-1495
5. Matsumoto K, Oki A, Furuta R et al (2010) Tobacco smoking and regression of low-grade cervical abnormalities. Cancer Sci 101:2065-2073
6. Matsumoto K, Oki A, Furuta R et al (2011) Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. Int J Cancer 128:2898-2910
7. Lane D, Gray EA, Mathur RS et al (2005) Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines. Am J Reprod Immunol 53:153-158
8. Nagano H, Yoshikawa H, Kawana T et al (1996) Association of multiple human papillomavirus types with vulvar neoplasias. J Obstet Gynaecol Res 22:1-8
9. Mandriota SJ, Jussila L, Jeltsch M et al (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO J 20:672-682
10. Obermair A, Bancher-Todesca D, Bilgi S et al (1997) Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Natl Cancer Inst 89:1212-1217
11. Branca M, Giorgi C, Santini D et al (2006) Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol 59:40-47
12. Van Trappen PO, Steele D, Lowe DG et al (2003) Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol 20:544-554
13. Kapeu AS, Luostarinen T, Jellum E et al (2009) Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol 169:480-488
14. Gunnell AS, Tran TN, Torrång A et al (2006) Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev 15:2141-2147
15. McCann MF, Irwin DE, Walton LA et al (1992) Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1:125-129
16. Prokopczyk B, Cox JE, Hoffmann D et al (1997) Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 89:868-873
17. Hellberg D, Nilsson S, Haley NJ et al (1998) Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 158:910-913
18. Trimble CL, Genkinger JM, Burke AE et al (2005) Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol 105:174-181
19. Berger F, Gage FH, Vijayaraghavan S (1998) Nicotinic receptorinduced apoptotic cell death of hippocampal progenitor cells. J Neurosci 18:6871-6881
20. Heusch WL, Maneckjee R (1998) Signaling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis (Oxf) 19:551-556
21. Pfeifer GP, Denissenko MF, Olivier M et al (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smokingassociated cancers. Oncogene 21:7435-7451
22. Holmgren L, O'Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149-153